Literature DB >> 2019434

Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system.

I G Charles1, B C Rodgers, A J Makoff, S N Chatfield, D E Slater, N F Fairweather.   

Abstract

The baculovirus expression vector p36C was used to express in cells of the insect Spodoptera frugiperda fragment C of tetanus toxin under the control of the strong polyhedrin promoter. Fragment C was expressed intracellularly at a high level and was soluble, allowing it to be purified by affinity chromatography with monoclonal antibody TT08. Purified fragment C from baculovirus was used to immunize mice and was shown to successfully prevent the symptoms of tetanus following a toxin challenge. The ganglioside-binding properties of baculovirus-derived fragment C were compared with those of intact tetanus toxin and native fragment C and were found to be dissimilar.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019434      PMCID: PMC257894          DOI: 10.1128/iai.59.5.1627-1632.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  p36C: an improved baculovirus expression vector for producing high levels of mature recombinant proteins.

Authors:  M J Page
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

2.  Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.

Authors:  L C Iacono-Connors; C S Schmaljohn; J M Dalrymple
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 3.  Baculoviruses as gene expression vectors.

Authors:  L K Miller
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

Review 4.  Baculovirus vectors for expression of foreign genes.

Authors:  C Y Kang
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

5.  Cloning and expression of functional fragment C of tetanus toxin.

Authors:  J L Halpern; W H Habig; E A Neale; S Stibitz
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Isolation and purification of two antigenically active, "complimentary" polypeptide fragments of tetanus neurotoxin.

Authors:  M Matsuda; M Yoneda
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis.

Authors:  I G Charles; G Dougan; D Pickard; S Chatfield; M Smith; P Novotny; P Morrissey; N F Fairweather
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.

Authors:  P W Angus; G W Mihaly; D J Morgan; R A Smallwood
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

10.  Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.

Authors:  A J Makoff; M D Oxer; M A Romanos; N F Fairweather; S Ballantine
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

View more
  9 in total

1.  Expression of tetanus toxin Fragment C in tobacco chloroplasts.

Authors:  John S Tregoning; Peter Nixon; Hiroshi Kuroda; Zora Svab; Simon Clare; Frances Bowe; Neil Fairweather; Jimmy Ytterberg; Klaas J van Wijk; Gordon Dougan; Pal Maliga
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Enhanced expression of recombinant proteins in insect cells using a baculovirus vector containing a bacterial leader sequence.

Authors:  T C Peakman; I G Charles; M A Sydenham; D R Gewert; M J Page; A J Makoff
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

3.  Characterization of recombinant tetanus toxin derivatives suitable for vaccine development.

Authors:  D Figueiredo; C Turcotte; G Frankel; Y Li; O Dolly; G Wilkin; D Marriott; N Fairweather; G Dougan
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.

Authors:  R Anderson; X M Gao; A Papakonstantinopoulou; M Roberts; G Dougan
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR.

Authors:  J C Marvaud; U Eisel; T Binz; H Niemann; M R Popoff
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 6.  The use of baculoviruses as expression vectors.

Authors:  I M Kidd; V C Emery
Journal:  Appl Biochem Biotechnol       Date:  1993 Aug-Sep       Impact factor: 2.926

7.  Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli.

Authors:  M A Clayton; J M Clayton; D R Brown; J L Middlebrook
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 8.  Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.

Authors:  Caroline Bayart; Angélique Mularoni; Nada Hemmani; Soumeya Kerachni; Joachim Jose; Patrice Gouet; Joseph Paladino; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-17

9.  Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.

Authors:  Robert P Webb; Theresa J Smith; Leonard A Smith; Patrick M Wright; Rebecca L Guernieri; Jennifer L Brown; Janet C Skerry
Journal:  Toxins (Basel)       Date:  2017-09-03       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.